This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Greenhalgh, D. A. Articles by Roop, D. R. Search for Related Content PubMed PubMed Citation Articles by Greenhalgh, D. A. Articles by Roop, D. R.

Paradoxical Tumor Inhibitory Effect of p53 Loss in Transgenic Mice Expressing Epidermal-targeted v-ras^Ha, v-fos, or Human Transforming Growth Factor ¹

Departments of Cell Biology [D. A. G., X-J. W., D. R. R.], Dermatology [D. A. G., D. R. R.], and Molecular Virology [L. A. D.], Baylor College of Medicine, Houston, Texas 77030

To investigate the effect of p53 tumor suppressor gene loss in the mouse skin model of multistage carcinogenesis, p53 knockout mice, generated by gene targeting (p53 -/-), were mated to transgenic mice expressing v-ras^Ha (HK1.ras), v-fos (HK1.fos), or human transforming growth factor (HK1.TGF) exclusively in the epidermis, by means of a keratin K1-based targeting vector (HK1). HK1-p53 transgenic progeny expressing wild-type p53 alleles (p53+/+) or hemizygous for the p53 knockout allele (p53+/-) were identical to parental HK1 lines and exhibited neonatal epidermal hyperplasia or wound-associated hyperplasia in adults, together with spontaneous or 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced benign papillomas. Mating to p53-/- did not lead to the expected tumorigenesis in adults. Instead, whereas HK1.ras or HK1.TGF transgenic mice null for p53 (HK1.ras-p53-/- and HK1.TGF-p53-/-, respectively) retained the neonatal epidermal hyperplasia phenotype, in adults, spontaneous and TPA-promoted papilloma formation was blocked. Similarly, wound-associated epidermal hyperplasia/hyperkeratosis, a hallmark of adult HK1.fos phenotypes, was completely absent in HK1.fos-p53 -/- mice. Histological, immunofluorescence, and bromodeoxyuridine labeling analysis of neonatal or adult epidermis in HK1-p53 transgenic genotypes +/+, +/-, and -/- for p53 revealed no obvious differences in morphology, expression of keratinocyte differentiation markers, or mitotic index attributed to p53 loss. To determine whether the paradoxical absence of papillomas centered on up-regulation of p53 target genes, WAF1/CIP1/p21 RNA expression levels were examined in TPA promotion experiments. WAF1/CIP1/p21 expression increased in response to TPA promotion in all HK1-p53 transgenic genotypes regardless of p53 status. However, in HK1-p53 null genotypes, although TPA-induced, p53-independent WAF1/CIP1/p21 expression was observed, no large increase in expression was associated with the observed paradoxical tumorigenesis block. These data suggest that epidermis is somewhat resistant to the neoplastic effects of p53 loss, possibly possessing several compensatory systems. Alternatively, there may be a requirement for p53 expression in response to TPA or a wound-promotion stimulus in mouse epidermis.

¹ This work was supported in part by NIH Grant CA52607 and a grant from the Texas Advanced Technology Program (ATP004949048).

² Present address: Department of Surgery, University of Liverpool, Liverpool L69 9BX, England.

³ To whom requests for reprints should be addressed, at Department of Cell Biology, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030.

Received 3/12/96. Accepted 7/25/96.

This article has been cited by other articles:

				M. R. Schneider, S. Werner, R. Paus, and E. Wolf Beyond Wavy Hairs: The Epidermal Growth Factor Receptor and Its Ligands in Skin Biology and Pathology Am. J. Pathol., July 1, 2008; 173(1): 14 - 24. [Abstract] [Full Text] [PDF]

				D. Yao, C. L. Alexander, J. A. Quinn, W.-C. Chan, H. Wu, and D. A. Greenhalgh Fos cooperation with PTEN loss elicits keratoacanthoma not carcinoma, owing to p53/p21WAF-induced differentiation triggered by GSK3{beta} inactivation and reduced AKT activity J. Cell Sci., May 15, 2008; 121(10): 1758 - 1769. [Abstract] [Full Text] [PDF]

				A. B. Martinez-Cruz, M. Santos, M. F. Lara, C. Segrelles, S. Ruiz, M. Moral, C. Lorz, R. Garcia-Escudero, and J. M. Paramio Spontaneous Squamous Cell Carcinoma Induced by the Somatic Inactivation of Retinoblastoma and Trp53 Tumor Suppressors Cancer Res., February 1, 2008; 68(3): 683 - 692. [Abstract] [Full Text] [PDF]

				T. K.S. Ku, D. C. Nguyen, M. Karaman, P. Gill, J. G. Hacia, and D. L. Crowe Loss of p53 Expression Correlates with Metastatic Phenotype and Transcriptional Profile in a New Mouse Model of Head and Neck Cancer Mol. Cancer Res., April 1, 2007; 5(4): 351 - 362. [Abstract] [Full Text] [PDF]

				D. Yao, C. L. Alexander, J. A. Quinn, M. J. Porter, H. Wu, and D. A. Greenhalgh PTEN Loss Promotes rasHa-Mediated Papillomatogenesis via Dual Up-Regulation of AKT Activity and Cell Cycle Deregulation but Malignant Conversion Proceeds via PTEN-Associated Pathways Cancer Res., February 1, 2006; 66(3): 1302 - 1312. [Abstract] [Full Text] [PDF]

				A. Krones-Herzig, S. Mittal, K. Yule, H. Liang, C. English, R. Urcis, T. Soni, E. D. Adamson, and D. Mercola Early Growth Response 1 Acts as a Tumor Suppressor In vivo and In vitro via Regulation of p53 Cancer Res., June 15, 2005; 65(12): 5133 - 5143. [Abstract] [Full Text] [PDF]

				W. Zhang, A. N. Hanks, K. Boucher, S. R. Florell, S. M. Allen, A. Alexander, D. E. Brash, and D. Grossman UVB-induced apoptosis drives clonal expansion during skin tumor development Carcinogenesis, January 1, 2005; 26(1): 249 - 257. [Abstract] [Full Text] [PDF]

				B. L. Schneider and M. Kulesz-Martin Destructive cycles: the role of genomic instability and adaptation in carcinogenesis Carcinogenesis, November 1, 2004; 25(11): 2033 - 2044. [Abstract] [Full Text] [PDF]

				J. Macdiarmid, D. Stevenson, D. H. Campbell, and J. B. Wilson The latent membrane protein 1 of Epstein-Barr virus and loss of the INK4a locus: paradoxes resolve to cooperation in carcinogenesis in vivo Carcinogenesis, July 1, 2003; 24(7): 1209 - 1218. [Abstract] [Full Text] [PDF]

				W. C. Weinberg and M. F. Denning P21WAF1 CONTROL OF EPITHELIAL CELL CYCLE AND CELL FATE Critical Reviews in Oral Biology & Medicine, November 1, 2002; 13(6): 453 - 464. [Abstract] [Full Text] [PDF]

				S. El-Hizawi, J. P. Lagowski, M. Kulesz-Martin, and A. Albor Induction of Gene Amplification as a Gain-of-Function Phenotype of Mutant p53 Proteins Cancer Res., June 1, 2002; 62(11): 3264 - 3270. [Abstract] [Full Text] [PDF]

				A. J. KNOX, L. CORBETT, J. STOCKS, E. HOLLAND, Y. M. ZHU, and L. PANG Human airway smooth muscle cells secrete vascular endothelial growth factor: up-regulation by bradykinin via a protein kinase C and prostanoid-dependent mechanism FASEB J, November 1, 2001; 15(13): 2480 - 2488. [Abstract] [Full Text] [PDF]

				J. A. Curran, F. S. Laverty, D. Campbell, J. Macdiarmid, and J. B. Wilson Epstein-Barr Virus Encoded Latent Membrane Protein-1 Induces Epithelial Cell Proliferation and Sensitizes Transgenic Mice to Chemical Carcinogenesis Cancer Res., September 1, 2001; 61(18): 6730 - 6738. [Abstract] [Full Text] [PDF]

				D. J. Long II, R. L. Waikel, X.-J. Wang, D. R. Roop, and A. K. Jaiswal NAD(P)H : quinone Oxidoreductase 1 Deficiency and Increased Susceptibility to 7,12-Dimethylbenz[a]-anthracene-Induced Carcinogenesis in Mouse Skin J Natl Cancer Inst, August 1, 2001; 93(15): 1166 - 1170. [Abstract] [Full Text] [PDF]

				A. Balmain and C. C.Harris Carcinogenesis in mouse and human cells: parallels and paradoxes Carcinogenesis, March 1, 2000; 21(3): 371 - 377. [Abstract] [Full Text] [PDF]

				S. Mueller, E. Cadenas, and A. H. Schönthal p21WAF1 Regulates Anchorage-independent Growth of HCT116 Colon Carcinoma Cells via E-Cadherin Expression Cancer Res., January 1, 2000; 60(1): 156 - 163. [Abstract] [Full Text]

				C. J. Kemp, K. Vo, and K. E. Gurley Resistance to skin tumorigenesis in DNAPK-deficient SCID mice is not due to immunodeficiency but results from hypersensitivity to TPA-induced apoptosis Carcinogenesis, November 1, 1999; 20(11): 2051 - 2056. [Abstract] [Full Text] [PDF]

				H. Ben-Bassat, S. Rosenbaum-Mitrani, Z. Hartzstark, R. Levitzki, M. Chaouat, Z. Shlomai, B. Y. Klein, N. Kleinberger-Doron, A. Gazit, R. Tsvieli, et al. Tyrphostins That Suppress the Growth of Human Papilloma Virus 16-Immortalized Human Keratinocytes J. Pharmacol. Exp. Ther., September 1, 1999; 290(3): 1442 - 1457. [Abstract] [Full Text]

				G. I. Topley, R. Okuyama, J. G. Gonzales, C. Conti, and G. P. Dotto p21WAF1/Cip1 functions as a suppressor of malignant skin tumor formation and a determinant of keratinocyte stem-cell potential PNAS, August 3, 1999; 96(16): 9089 - 9094. [Abstract] [Full Text] [PDF]

				C. Go, P. Li, and X.-J. Wang Blocking Transforming Growth Factor {beta} Signaling in Transgenic Epidermis Accelerates Chemical Carcinogenesis: A Mechanism Associated with Increased Angiogenesis Cancer Res., June 1, 1999; 59(12): 2861 - 2868. [Abstract] [Full Text] [PDF]

				W. C. Weinberg, E. Fernandez-Salas, D. L. Morgan, A. Shalizi, E. Mirosh, E. Stanulis, C. Deng, H. Hennings, and S. H. Yuspa Genetic Deletion of p21WAF1 Enhances Papilloma Formation but not Malignant Conversion in Experimental Mouse Skin Carcinogenesis Cancer Res., May 1, 1999; 59(9): 2050 - 2054. [Abstract] [Full Text] [PDF]